Microchip RT-PCR COVID-19 Detection System Announced
Apr 25 2020 Read 1326 Times
The current pandemic situation has created a demand for test kits that can be run with less amount of reagents while generating faster test results. Lumex Instruments’ microchip real-time PCR analyser AriaDNA, by detecting SARS-CoV-2, has proven its ability to meet this demand. The Microchip RT-PCR COVID-19 Detection System based on AriaDNA enables to test up to seven patient samples in one run, which takes less than an hour, with low reagent consumption. Currently the system is for research use only (RUO).
During this pandemic situation, erratic supply of lab wares and reagents, as well as bottlenecks created due to high demand and short supply of the test reagents, has created a delay in getting the population tested for COVID-19. Worldwide calls for widespread testing has skyrocketed the amount of requests for PCR reagent supply. Current real-time PCR assays and PCR instruments consume large volume of reagents (20 μl reaction), since assays are performed in PCR tubes or array plates. Lumex Instruments has developed the Microchip RT-PCR COVID-19 detection system with reagent consumption as low as 1.2 μl reaction. The system overcomes the limitation of reagents availability during COVID-19 outbreak by 10-fold increasing number of samples that can be analysed from a single box of reagents from 300 to 3,000.
The Microchip RT-PCR COVID-19 detection system provides sensitive, specific, and fast detection of SARS-CoV-2 viral RNA. The system uses a pre-loaded microchip kit with primers and probes lyophilised in the microchip. The N1 and N2 primer-probes target regions within the SARS-CoV-2 nucleocapsid gene (N), and HsRPP30 targets RNase P gene present in the human genome. The system relies on the use of the US Center for Disease Control and Prevention (CDC) approved test kits and instructions.
Fast analysis, shipment under ambient conditions, and convenient process of PCR analysis are among key features of the Microchip RT-PCR COVID-19 detection system. Ease of use with lyophilised PCR reagents in the microchips significantly improves reliability of analysis in fast-responder settings by reducing operator-associated errors.
Currently the Microchip RT-PCR COVID-19 Detection System is suitable for research use only. Meanwhile, Lumex Instruments applied for Health Canada approval at the end of March.
Real-time reverse transcription polymerase chain reaction (RT-PCR) is the standard method of SARS-CoV-2 detection. Testing is performed on respiratory samples such as nasopharyngeal or oropharyngeal swabs, sputum, lower respiratory tract aspirates, bronchoalveolar lavage, and nasopharyngeal wash/aspirate or nasalaspirate.
More information online
Do you like or dislike what you have read? Why not post a comment to tell others / the manufacturer and our Editor what you think. To leave comments please complete the form below. Providing the content is approved, your comment will be on screen in less than 24 hours. Leaving comments on product information and articles can assist with future editorial and article content. Post questions, thoughts or simply whether you like the content.
In This Edition Articles - Export experts talk Corona Virus - Automated cell counting shouldn’t cost the earth Laboratory Products - Spectrophotometer Linearity Validation - Analysi...
View all digital editions
May 31 2020 Houston, TX, USA
May 31 2020 Baltimore, MD, USA
Jun 11 2020 Brussels, Belgium
Jun 20 2020 San Diego, CA, USA
Jun 30 2020 Nuremberg, Germany